Safety and Efficacy of EXG102-031, a Novel AAV-Based Gene Therapy for Neovascular AMD

被引：0
|
作者：
Wu, Zhenhua [1 ]
Dai, Li [1 ]
Song, Chunjuan [1 ]
Shen, Jikui [2 ]
Formica, Raquel [2 ]
Wang, Lijun [1 ]
Campochiaro, Peter A. [2 ]
Ye, Guo-Jie [1 ]
机构：
[1] Exegenesis Bio Inc, Lower Gwynedd, PA USA
[2] Johns Hopkins Univ Hosp, Sch Med, Baltimore, MD USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1139
引用
收藏
页码：545 / 545
页数：1
相关论文
共 50 条
  • [1] Efficacy Evaluation of EXG102-031, A Novel AAV-based Gene Therapy for Neovascular AMD in a Mouse Model of VEGF-A-induced Exudative Retinal Detachment vascular leakage Mouse Model
    Ye, Guojie
    Shen, Jikui
    Dai, Li
    Formica, Raquel
    Wang, Lijun
    Wu, Zhenhua
    Campochiaro, Peter A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] A novel AAV-based gene therapy for glaucoma
    Wu, Ling
    Maturana, Carola
    Yao, Zuliang
    Wang, Wei
    Liang, Bo
    Hong, Laura
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [3] Clinical Safety and Efficacy of EXG001-307 in SMA Type 1 Patients: A Next-Generation AAV-Based Gene Therapy
    Wu, Zhenhua
    Song, Chunjuan
    Li, Wenhui
    Li, Xiaojing
    Zhu, Xiaomei
    Li, Hui
    Yang, Meijia
    Yang, Wenshu
    Ji, Rui
    Lu, Kuan
    Zhang, Yanna
    Li, Haifeng
    Wang, Lijun
    Ye, Guo-jie
    Shu, Qiang
    Wang, Yi
    MOLECULAR THERAPY, 2024, 32 (04) : 320 - 320
  • [4] Safety and Efficacy of an AAV-Based Liver Gene Therapy for Crigler-Najjar Syndrome
    Collaud, Fanny
    Ronzitti, Giuseppe
    Bortolussi, Giulia
    Guianvarc'h, Laurence
    Veron, Philippe
    Charles, Severine
    Vidal, Patrice
    Sola, Marcelo Simon
    Leborgne, Christian
    Rundwasser, Stephanie
    Dejoint, Ludivine
    Goncalves, Delphine
    Van Wittenberghe, Laetitia
    Gjata, Bernard
    Martin, Samia
    Le Bec, Christine
    Bosma, Piter J.
    Muro, Andres F.
    Hebben, Matthias
    Mingozzi, Federico
    MOLECULAR THERAPY, 2017, 25 (05) : 188 - 189
  • [5] Development of Novel AAV-Based Gene Therapy for Cardiac Disease
    Whittlesey, K.
    Brooks, G.
    Szymanski, P.
    Beliakoff, G.
    Nye, J.
    Croze, R.
    Schmitt, C.
    Bickta, J.
    Barglow, K.
    Kotterman, M.
    Francis, P.
    Schaffer, D.
    Kirn, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] A Novel AAV-Based Gene Therapy for Spinal Muscular Atrophy
    Wu, Zhenhua
    Zhu, Peixin
    Wang, Qingzeng
    Li, Zhongwan
    Chen, Shuyuan
    Dai, Li
    Li, Junhui
    Wang, Lijun
    Ye, Guojie
    MOLECULAR THERAPY, 2022, 30 (04) : 257 - 257
  • [7] A novel AAV-based miQURE gene therapy for SCA3
    Toonen, L. J. A.
    Nobre, R.
    Haas, E.
    Huebener-Schmid, J.
    Martier, R.
    Valles, A.
    Higgens, J. J.
    van Deventer, S.
    Nguyen, H. P.
    Pereira de Almeida, L.
    Konstantinova, P.
    Evers, M. M.
    HUMAN GENE THERAPY, 2019, 30 (11) : A91 - A92
  • [8] TYMS as a novel target for AAV-based therapy
    Vijayakurup, Vinod
    Meyer, Benjamin
    Nawab, Akbar
    Kaye, Frederic J.
    Guijarro, Maria V.
    Zajac-Kaye, Maria
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Safety, Toxicology and Efficacy of a Lung-Directed AAV-Based Gene Therapy for α1-Antitrypsin Deficiency
    Chiuchiolo, Maria J.
    Hackett, Neil R.
    Frenk, Esther Z.
    Hwang, Yihharn
    Qiu, Jianping
    Benson, Janet
    Wang, Gensheng
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    MOLECULAR THERAPY, 2013, 21 : S43 - S44
  • [10] AAV-based gene replacement: The promise of gene therapy for deafness
    Qi, Jieyu
    Zhang, Liyan
    Chai, Renjie
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (02):
12345